BCR-ABL generated by the chromosomal translocation t(9;22)(q34;q11) in hematopoietic stem cells constitutively activates tyrosine kinase on its own and leads to CML [1]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.